Processa Pharmaceuticals, Inc. - Common Stock (PCSA)
0.2600
+0.0349 (15.50%)
NASDAQ · Last Trade: Jun 17th, 7:11 PM EDT
Detailed Quote
Previous Close | 0.2251 |
---|---|
Open | 0.5867 |
Bid | 0.2649 |
Ask | 0.2686 |
Day's Range | 0.2000 - 0.7854 |
52 Week Range | 0.1500 - 3.100 |
Volume | 574,913,187 |
Market Cap | 3.09M |
PE Ratio (TTM) | -0.0844 |
EPS (TTM) | -3.1 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 7,011,033 |
Chart
About Processa Pharmaceuticals, Inc. - Common Stock (PCSA)
Processa Pharmaceuticals Inc. is a biopharmaceutical company focused on the development of innovative therapeutic solutions for patients with unmet medical needs. The company primarily concentrates on advancing treatments for various cancer types and gastrointestinal disorders by utilizing its proprietary drug candidates. Through rigorous research and clinical trials, Processa aims to improve patient outcomes and enhance the quality of life for those affected by serious health conditions. Its strategic approach includes leveraging repurposed existing therapies as well as developing novel compounds, highlighting its commitment to addressing significant healthcare challenges. Read More
News & Press Releases
Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention.
Via Chartmill · June 17, 2025
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Via Chartmill · June 17, 2025
Peraso Inc. (NASDAQ: PRSO), a leader in millimeter wave (mmWave) wireless technology, has announced the initial production shipments of its next-gen 60 GHz wireless communication platform, marking a major step into the global tactical communications and battlefield safety market.
Via AB Newswire · June 17, 2025
Processa Pharmaceuticals' stock is surging after licensing a gastroparesis drug to Intact Therapeutics. The deal promises milestone payments and royalties for Processa.
Via Benzinga · June 17, 2025
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · April 30, 2025
Via Benzinga · April 30, 2025
Via Benzinga · April 24, 2025
After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · April 17, 2025
Via Benzinga · April 9, 2025
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · April 3, 2025
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
Via Chartmill · April 3, 2025
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
Via Chartmill · April 2, 2025
Via Benzinga · April 2, 2025
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · April 2, 2025
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · April 2, 2025
Via Benzinga · April 2, 2025

Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · January 30, 2025

Via Benzinga · January 30, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · January 29, 2025